162 related articles for article (PubMed ID: 31418345)
1. Insulin Therapy, Insulin Resistance and Vascular Dysfunction.
Vázquez MC; Sobrevia L
Curr Vasc Pharmacol; 2019; 17(5):429-431. PubMed ID: 31418345
[No Abstract] [Full Text] [Related]
2. Involvement of Intracellular pH in Vascular Insulin Resistance.
Ramírez MA; Beltrán AR; Araya JE; Cornejo M; Toledo F; Fuentes G; Sobrevia L
Curr Vasc Pharmacol; 2019; 17(5):440-446. PubMed ID: 30205799
[TBL] [Abstract][Full Text] [Related]
3. Compensatory mechanisms of pancreatic beta cells: insights into the therapeutic perspectives for diabetes.
Regazzi R; Dalle S; Abderrahmani A
J Diabetes Res; 2014; 2014():217387. PubMed ID: 25133190
[No Abstract] [Full Text] [Related]
4. [Geriatric aspects of diabetes mellitus and diabetic angiopathies].
Efimov ES
Ter Arkh; 1983; 55(12):64-6. PubMed ID: 6665721
[No Abstract] [Full Text] [Related]
5. Hypertension in diabetes: the role of the vasculature.
Stern N; Marcus Y
Curr Hypertens Rep; 2004 Apr; 6(2):90-7. PubMed ID: 15010010
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of metabolic mischief--meritorious or meretricious?
Service FJ
Endocr Pract; 2003; 9(1):101-2. PubMed ID: 12917099
[No Abstract] [Full Text] [Related]
7. Insulin treatment and diabetic vascular complications.
Brodsky JB; Ring C; Palmer JP
JAMA; 1979 Jun; 241(26):2783-4. PubMed ID: 448830
[No Abstract] [Full Text] [Related]
8. [Disorders of the cardiovascular system in patients with diabetes mellitus].
Kliachko VR; Mazovetskiĭ AG; Slavina LS
Kardiologiia; 1974 Oct; 14(10):150-8. PubMed ID: 4280467
[No Abstract] [Full Text] [Related]
9. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
10. Antidiabetic potential of saffron and its active constituents.
Yaribeygi H; Zare V; Butler AE; Barreto GE; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8610-8617. PubMed ID: 30515777
[TBL] [Abstract][Full Text] [Related]
11. New drugs and clinical trials in diabetes and hypertension.
Nilsson P
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():64-9. PubMed ID: 9288549
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction, inflammation and diabetes.
Dandona P; Aljada A; Chaudhuri A; Mohanty P
Rev Endocr Metab Disord; 2004 Aug; 5(3):189-97. PubMed ID: 15211090
[No Abstract] [Full Text] [Related]
13. [Effect of the diabetic metabolic disorder on the arterial elasticity. With reference to sex, age, blood pressure, duration, tablet- and insulin-treated diabetics, relative body weight, metabolic behavior and cholesterol level].
Schimmler W
Arch Kreislaufforsch; 1970; 62(1):25-55. PubMed ID: 5524159
[No Abstract] [Full Text] [Related]
14. Microcirculation in insulin resistance and diabetes: more than just a complication.
Wiernsperger NF; Bouskela E
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S77-87. PubMed ID: 14502104
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
Lunder M; Janić M; Šabovič M
Curr Vasc Pharmacol; 2019; 17(1):6-15. PubMed ID: 29412116
[TBL] [Abstract][Full Text] [Related]
16. Early insulinization to prevent diabetes progression.
Raz I; Mosenzon O
Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S190-7. PubMed ID: 23882045
[No Abstract] [Full Text] [Related]
17. Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus.
Palumbo PJ
J Diabetes Complications; 1998; 12(2):110-9. PubMed ID: 9559489
[TBL] [Abstract][Full Text] [Related]
18. Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients.
Yaribeygi H; Butler AE; Barreto GE; Sahebkar A
J Cell Physiol; 2019 Mar; 234(3):2436-2446. PubMed ID: 30191997
[TBL] [Abstract][Full Text] [Related]
19. [Diabetes. A daily problem: glycemic equilibrium. A long term problem: vascular complications. Discussion].
Sem Hop Ther; 1973 Sep; 49 Spec No():111-5. PubMed ID: 4804046
[No Abstract] [Full Text] [Related]
20. Cardiovascular effects of insulin sensitizers in diabetes.
Jawa A; Fonseca V
Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
